Active substance
Folinate
- SFDA 8
- NHS prices 2
- WHO EML 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| Calcium Folinate Hainan | 500 mg | powder for solution for injection · Intramuscular and intravenous use | 1 Vial | SAR 217.50 | Generic · Prescription | Hainan Poly Pharm. Co., Ltd. | Valid |
| Calcium Folinate Hainan | 350 mg | powder for solution for injection · Intramuscular and intravenous use | 1 Vial | SAR 140.05 | Generic · Prescription | Hainan Poly Pharm. Co., Ltd. | Valid |
| Calcium Folinate Hainan | 200 mg | powder for solution for injection · Intramuscular and intravenous use | 1 Vial | SAR 93.35 | Generic · Prescription | Hainan Poly Pharm. Co., Ltd. | Valid |
| Calcium Folinate Hainan | 100 mg | powder for solution for injection · Intramuscular and intravenous use | 1 Vial | SAR 77.75 | Generic · Prescription | Hainan Poly Pharm. Co., Ltd. | Valid |
| Calcium Folinate Hainan | 50 mg | powder for solution for injection · Intramuscular and intravenous use | 1 Vial | SAR 50.85 | Generic · Prescription | Hainan Poly Pharm. Co., Ltd. | Valid |
| Calcium folinate Kabi | 10 mg/ml | Solution for injection/infusion · Intramuscular and intravenous use | 10 Vial | SAR 264.25 | Generic · Prescription | Fresenius Kabi Deutschland GmbH | Valid |
| Calcium folinate Kabi | 10 mg/ml | Solution for injection/infusion · Intramuscular and intravenous use | 10 Vial | SAR 528.50 | Generic · Prescription | Fresenius Kabi Deutschland GmbH | Valid |
| CALCIUM LEUCOVORIN TAB 15MG | 15 mg | Tablet · Oral use | 10 Blister | SAR 266.90 | NCE · Prescription | LEDERLE | Withdrawn by MAH · Not Marketed |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| NHS Drug Tariff | Calcium folinate 15mg tablets | £37.85 | 10 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Calcium folinate 15mg tablets | £85.74 | 30 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
WHO WHO Model List of Essential Medicines (2025)
- 8.2.1. Cytotoxic medicines · complementary
Burkitt lymphoma including Burkitt leukaemia; Osteosarcoma of bone or articular cartilage of unspecified sites; Malignant neoplasms of rectum; Malignant neoplasm metastasis in large intestine; Malignant neoplasms of colon; Malignant trophoblastic neoplasms of placenta
Parenteral > General injections > unspecified: 3 mg per mL in 10 mL ampoule; 7.5 mg per mL in 2 mL ampoule; 10 mg per mL in 5 mL ampoule | Oral > Solid > tablet: 15 mg; 5 mg; 25 mg
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.